Colony-Forming Unit Assays
| Stimulation . | EPO/GM-CSF . | EPO/IL-3 . | EPO/G-CSF . |
|---|---|---|---|
| PB | |||
| Patient no. 1 | 0 ± 0 | 0 ± 0 | 143 ± 16 |
| Controls | 55 ± 20 | 45 ± 15 | 84 ± 46 |
| BM | |||
| Patient no. 2 | 4 ± 0 | 5 ± 0 | 372 ± 15 |
| Controls | 325 ± 55 | 456 ± 79 | 439 ± 66 |
| Thawed BM | |||
| Patient no. 3 | 0 ± 0 | 0 ± 0 | 72 ± 15 |
| Controls | 98 ± 65 | 135 ± 76 | 182 ± 78 |
| Stimulation . | EPO/GM-CSF . | EPO/IL-3 . | EPO/G-CSF . |
|---|---|---|---|
| PB | |||
| Patient no. 1 | 0 ± 0 | 0 ± 0 | 143 ± 16 |
| Controls | 55 ± 20 | 45 ± 15 | 84 ± 46 |
| BM | |||
| Patient no. 2 | 4 ± 0 | 5 ± 0 | 372 ± 15 |
| Controls | 325 ± 55 | 456 ± 79 | 439 ± 66 |
| Thawed BM | |||
| Patient no. 3 | 0 ± 0 | 0 ± 0 | 72 ± 15 |
| Controls | 98 ± 65 | 135 ± 76 | 182 ± 78 |
Granulocyte-macrophage colony-forming unit assay from cells of βc-deficient AML patients with PAP and from healthy controls. Each value represents the mean of triplicate determinations.